Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group's Subsidiary Paths Innovations Limited
Regulatory News: Aptorum Group Limited , today announced that its wholly owned subsidiary Aptorum Therapeutics Limited has entered into a non-binding Letter of Intent and Term Sheet to merge ... | May 1, 2023
United States San Diego Singapore Agency For Science Aptorum Therapeutics Limited Aptorum Group Or Company Aptorum Group Form
Source: marketscreener.com